Sign up here.
Performance metrics need to be reviewed with respect to the end goals of the study they are being measured on. They should be looked at in context with those goals and with an understanding of their effect on other aspects of the study. Status reports should accurately report the Key Performance Metrics and provide insight into their implications if they remain unchanged. This would allow for strategy to be focused on what needs to be done to enhance performance. Status reports with metrics can be a vehicle to consistent communication between upper and lower level management.
What you will learn:
• How to use metrics to enable discussions with upper management
• How to focus results / goals
• Using metrics to guide strategy
• Understand that metrics should not be viewed in a silo
Presented by:
John C. Burnett, PMP
Founder / CEO
JaPa Associates, Inc.
John is a seasoned Clinical Research Professional with nearly 15 years experience working in Clinical Trials, including 8 years in senior level management roles. John has worked for major pharma and biotech companies such as Vivus, Pfizer, Amgen, Scios under Sr. CRA, Clinical Project Manager and Clinical Trial Manager positions.
Sign up for this complimentary web seminar here:
http://bit.ly/7BFIvH
|
Share this article with your social network, just click below to share now!
|
|
|
